Chronic patellofemoral pain. Pain in knee
Conditions
Interventions
Intervention 1: Intervention group : Stretching exercise with dry needling group: People with patellofemoral pain who in addition to stretching exercises of the gastrocnemius, soleus and peroneal musc
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: People 18 to 45 years old with unilateral patellofemoral pain Complaints of anterior knee pain in at least 2 daily activities include: prolonged sitting, going up and down stairs, squatting, kneeling, jumping, and running. Report of pain when touching the internal and external patellar procedures and positive Clark test in knee extension and sitting position. Gradual onset of symptoms with no history of trauma or injury for at least the past 3 months. Kujala score level 80-50 with moderate disability. Have an average pain level of 4-7 on a numerical pain scale over the past week. Have at least one active or latent trigger point in each group of gastrosoleus muscles and peroneal muscles of the affected side, which is felt as a taut, sensitive and painful bundle. People with BMI=18.5-25
Exclusion criteria
Exclusion criteria: Injury of knee joint such as rupture of the meniscus or ligaments and tendons of the knee, osteoarthritis of the knee joint, dislocation of the patella Ankle injuries such as rupture of ligaments and tendons, ankle osteoarthritis, dislocation of ankle Ankle sprain in the last 6 months History of surgery and trauma to the entire lower extremity in the last 6 months Neurological disorders of the lower extremities and neuropathic pain Athletes who engage in certain sports activities at least two hours a day and three times a week People who have received physiotherapy and dry needling for patellofemoral pain in the last 6 months Contraindications to the use of dry needling: - The presence of metabolic diseases such as diabetes, rheumatic diseases - Local or systemic infections - Local ulcers on the skin - Pregnancy - Respiratory and cardiovascular problems (peripheral vascular disease, cancer, hepatitis, AIDS and any Malignancy - Taking immunosuppressive drugs - Any fear and reluctance to needle (needle phobia) - Epilepsy and mental health problems - Bleeding disorders and taking anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before the intervention, after the end of the treatment (at the end of the second week) and two weeks after the end of the treatment as a follow-up. Method of measurement: NPRS.;Pain pressure threshold. Timepoint: Before the intervention, after the end of the treatment (at the end of the second week) and two weeks after the end of the treatment as a follow-up. Method of measurement: Pressure algometer device.;Function. Timepoint: Before the intervention, immediately after the end of the treatment (at the end of the second week) and two weeks after the end of the treatment as a follow-up. Method of measurement: Kujala questionnaire.;ROM of dorsiflexion and inversion. Timepoint: Before the intervention, immediately after the end of the treatment (at the end of the second week) and two weeks after the end of the treatment as a follow-up. Method of measurement: Goniometer.;Functional tests. Timepoint: Before the intervention, immediately after the end of the treatment (at the end of the second week) and two weeks after the end of the treatment as a follow-up. Method of measurement: Step down and anteromedial lunge tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Abbasi
Shiraz University of Medical Sciences
Outcome results
None listed